When you don’t need an EUA for SARS-CoV-2 testing

When you don’t need an EUA for SARS-CoV-2 testing

On March 25, 2020, the US Food and Drug Administration (FDA) held the first of a series of virtual town halls they will be holding to answer technical questions about developing, validating, and implementing…

Read More

The BiosearchTech Blog

Most Popular

How do SARS-CoV-2 variants affect PCR assays for COVID-19 testing?

Posted on Tue, May 04, 2021 @ 09:03 AM

Researchers have identified several variants of SARS-CoV-2 since they sequenced the original viral strain responsible ...
Read More

Topics: Molecular Diagnostics, Coronavirus, MDx, SARS-CoV-2, Variants

Building resilience into SARS-CoV-2 testing workflows: considerations for choosing an RNA isolation method

Posted on Wed, Oct 21, 2020 @ 09:00 AM

As we start to close in on a full year of the COVID-19 pandemic, molecular diagnostics labs are still facing supply ...
Read More

Topics: Molecular Diagnostics, Genomics, Coronavirus

Pressing COVID-19 testing issues of today and the near future

Posted on Wed, Aug 26, 2020 @ 07:57 AM

Following up with the panelists from our recent COVID-19 webinar, Part 3 of 3 In the previous two blog posts in this ...
Read More

Topics: Molecular Diagnostics, Genomics, Coronavirus

Sensitivity and accuracy in COVID-19 testing

Posted on Wed, Aug 19, 2020 @ 07:56 AM

Following up with the panelists from our recent COVID-19 webinar, Part 2 of 3 In the face of a rapidly evolving ...
Read More

Topics: Molecular Diagnostics, Genomics, Coronavirus

Scaling up COVID-19 viral testing

Posted on Wed, Aug 12, 2020 @ 07:47 AM

Following up with the panelists from our recent COVID-19 webinar, Part 1 of 3 The COVID-19 pandemic has presented ...
Read More

Topics: Molecular Diagnostics, Genomics, Coronavirus

Enabling a rapid response to COVID-19 by Honeywell and LGC, Biosearch Technologies

Posted on Wed, Jul 29, 2020 @ 12:40 PM

As countries worldwide begin to ease lockdown restrictions during the pandemic and prepare to return to “normal” ...
Read More

Topics: Molecular Diagnostics, Genomics, qPCR, Coronavirus

Robust supply chains and open testing systems: How our AgBio roots meet the FDA's EUA process to enable solutions to the COVID-19 pandemic

Posted on Tue, May 19, 2020 @ 08:18 AM

It may seem strange that a company known for transforming the global seed breeding industry is uniquely positioned to ...
Read More

Topics: Molecular Diagnostics, Genomics, qPCR, Coronavirus

Behind the scenes: How our oligo synthesis team contributes to the reliability of your assays

Posted on Thu, Apr 30, 2020 @ 02:13 PM

We’re not rejecting you, just your oligo PCR is arguably one of the most enabling technologies of modern molecular ...
Read More

Topics: Molecular Diagnostics, Genomics, Coronavirus, Oligo synthesis

When you don’t need an EUA for SARS-CoV-2 testing

Posted on Fri, Apr 10, 2020 @ 03:00 PM

On March 25, 2020, the US Food and Drug Administration (FDA) held the first of a series of virtual town halls they will ...
Read More

Topics: Molecular Diagnostics, Coronavirus

Addressing COVID-19 together: LGC, Biosearch Technologies and Shanghai Liferiver Biotechnology Co., Ltd.

Posted on Tue, Mar 31, 2020 @ 10:13 AM

In the nearly three months since the first confirmed case of COVID-19, the outbreak has become a global crisis, with ...
Read More

Topics: Molecular Diagnostics, Custom Oligos, Genomics, Coronavirus

What diagnostic test makers and CLIA labs in the US need to know about Emergency Use Authorization (EUA)

Posted on Tue, Mar 24, 2020 @ 11:58 AM

*Since the original publication of this blog, LGC, Biosearch Technologies is now the only acceptable commercial ...
Read More

Topics: Molecular Diagnostics, Genomics, Coronavirus

Coronavirus outbreak: Collaboration to meet the challenge

Posted on Mon, Mar 16, 2020 @ 12:30 PM

Coronavirus, or COVID-19, is an infectious virus that is spreading rapidly around the world and the World Health ...
Read More

Topics: Molecular Diagnostics, Genomics, Coronavirus

Subscribe to our blog

About LGC, Biosearch Technologies

LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.

Posts by popularity

Follow @BiosearchTech on Twitter

Become a Fan on Facebook!